CYCLAPEN-W Drug Patent Profile
✉ Email this page to a colleague
When do Cyclapen-w patents expire, and when can generic versions of Cyclapen-w launch?
Cyclapen-w is a drug marketed by Wyeth Ayerst and is included in two NDAs.
The generic ingredient in CYCLAPEN-W is cyclacillin. There are two drug master file entries for this compound. Additional details are available on the cyclacillin profile page.
Summary for CYCLAPEN-W
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 3,891 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CYCLAPEN-W at DailyMed |
US Patents and Regulatory Information for CYCLAPEN-W
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | CYCLAPEN-W | cyclacillin | FOR SUSPENSION;ORAL | 050508-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | CYCLAPEN-W | cyclacillin | TABLET;ORAL | 050509-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | CYCLAPEN-W | cyclacillin | FOR SUSPENSION;ORAL | 050508-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | CYCLAPEN-W | cyclacillin | FOR SUSPENSION;ORAL | 050508-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | CYCLAPEN-W | cyclacillin | TABLET;ORAL | 050509-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |